Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Arash Haghikia(German Centre for Cardiovascular Research), Ulf Landmesser(Deutsches Herzzentrum der Charité), Stefan Bereswill(Humboldt-Universität zu Berlin), Oliver Soehnlein(University of Münster), Markus M. Heimesaat(Humboldt-Universität zu Berlin), Johann Roessler(German Centre for Cardiovascular Research), Emiel P. C. van der Vorst(RWTH Aachen University), Johannes Kaisler(St. Josef-Hospital), Aiden Haghikia(Friedrich-Alexander-Universität Erlangen-Nürnberg), Uta Ceglarek(Leipzig University), Geraldine Rauch(Zimmer Biomet (Germany)), Roodline Cineus(Charité - Universitätsmedizin Berlin), Stanley L. Hazen(Cleveland Clinic), Ina Nemet(Cleveland Clinic Lerner College of Medicine), Fredrik Bäckhed(Sahlgrenska University Hospital), Andrzej Jasina(Charité - Universitätsmedizin Berlin), Ute Seeland(Humboldt-Universität zu Berlin), P. A. Schumann(German Centre for Cardiovascular Research), Ahmed N. Hegazy(Humboldt-Universität zu Berlin), Christopher Strauch(Cleveland Clinic Lerner College of Medicine), Ralf Gold(St. Josef-Hospital), Yvonne Döring(University of Bern), Chinmay Dwibedi(University of Gothenburg), Philipp Heinze(Charité - Universitätsmedizin Berlin), Valentina Tremaroli(University of Gothenburg), Dominik N. Müller(Max Delbrück Center), Vanasa Nageswaran(Deutsches Herzzentrum der Charité), David Schmidt(Charité - Universitätsmedizin Berlin), Friederike Zimmermann(German Centre for Cardiovascular Research), David M. Leistner(University of Salzburg), Nicolle Kränkel(Leipzig Heart Institute), Annette Aigner(Zimmer Biomet (Germany))
Cited by 349
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k